Search results
Found 9262 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
All Publications
Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Groups & Themes
The Institute currently houses five research groups. Research in the Institute focuses on ten themes, each formed around collaborations between researchers in Oxford and China. Some build upon and expand on-going successful collaborations that are currently part of the CTI, others present exciting, new collaborative opportunities within the Institute.